✦ LIBER ✦

Deep sequencing of the microRNA transcriptome in current, former, and never smokers with lung adenocarcinoma

✍ Scribed by Teresa W Wang, Josh D Campbell, Lingqi Luo, Gang Liu, Ji Xiao…

Book ID: 120684710
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 81 KB
Volume: 6
Category: Article
ISSN: 1753-6561
DOI: 10.1186/1753-6561-6-S6-P38

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The frequency and impact of ROS1 rearran

The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma

✍ Kim, H. R.; Lim, S. M.; Kim, H. J.; Hwang, S. K.; Park, J. K.; Shin, E.; Bae, M. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 241 KB

Comparison of targeted next-generation s

Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma

✍ Han, Ji-Youn; Kim, Sun Hye; Lee, Yeon-Su; Lee, Seung-Youn; Hwang, Jung-Ah; Kim, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 876 KB

Randomized Phase II Trial of Erlotinib A

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

✍ Janne, P. A.; Wang, X.; Socinski, M. A.; Crawford, J.; Stinchcombe, T. E.; Gu, L 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 170 KB

First-SIGNAL: First-Line Single-Agent Ir

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

✍ Han, J.-Y.; Park, K.; Kim, S.-W.; Lee, D. H.; Kim, H. Y.; Kim, H. T.; Ahn, M. J. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB